Background: Given the recent boom of the cosmetic industry, there is a wealth of new products available to patients and physicians, including soft-tissue fillers. Bio-Alcamid polyacrylamide gel (Polymekon, Milan, Italy) is a filler that has potential to cause adverse reactions.
Observations: Two patients who had previously been treated with Bio-Alcamid outside of the United States presented with different manifestations of inflammatory responses to the product. These reactions were challenging to treat.
Conclusions: Despite claims of safety, Bio-Alcamid and possibly other soft-tissue fillers available worldwide have the potential to cause adverse reactions. Physicians should be aware of the various presentations and treatment options for these reactions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/archdermatol.2009.266 | DOI Listing |
Facial Plast Surg
December 2014
Department of Dermatology, Inselspital, Universitätsspital Bern, Bern, Switzerland.
Injectable fillers nowadays represent a pillar in facial rejuvenation and make a significant contribution to the success of the treatment. Despite their obvious benefits, a wide range of possible complications such as immediate, late, delayed, temporary, or irreversible adverse effects have to be respected. Differentiating the various filler materials, these effects are assigned to histopathology findings and currently available treatment options.
View Article and Find Full Text PDFJ Drugs Dermatol
December 2011
Dermatology Surgery and Laser Center, New York, NY, USA.
Polymer hydrogels have been used for many years in European and Asian countries, and these products are often considered to be the same material in different packaging. This, however, is not the case. Performance and safety profiles depend on many factors including chemical and physical characteristics (including rheological properties), manufacturing process and control (cross linking, impurities, stability, etc.
View Article and Find Full Text PDFArch Dermatol
November 2009
SkinCare Physicians, 1244 Boylston St, Ste 103, Chestnut Hill, MA 02467, USA.
Background: Given the recent boom of the cosmetic industry, there is a wealth of new products available to patients and physicians, including soft-tissue fillers. Bio-Alcamid polyacrylamide gel (Polymekon, Milan, Italy) is a filler that has potential to cause adverse reactions.
Observations: Two patients who had previously been treated with Bio-Alcamid outside of the United States presented with different manifestations of inflammatory responses to the product.
J Craniofac Surg
July 2008
School of Medicine and Surgery, University of Rome La Sapienza, Rome, Italy.
Facial deficit diseases are corrected by biomaterial implantation. The ideal biomaterial should be easy to implant and remove and simple to be identified by a low-dose radiation and low-cost radiologic technique. The purpose of this work was to evaluate ultrasonography (US) as a technique in monitoring biomaterial status after operation.
View Article and Find Full Text PDFJ Cosmet Laser Ther
December 2005
Background: In Europe, numerous dermal fillers have been utilized for the past decade. A lot of drawbacks have been reported and sometimes, severe complications occurred.
Objective: Our purpose is to report the clinical aspects of the adverse reactions following injections of some of the dermal fillers.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!